171 related articles for article (PubMed ID: 36756387)
1. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
[TBL] [Abstract][Full Text] [Related]
4. The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.
Zhang Y; Ma JP; Weng JC; Wang L; Wu Z; Li D; Zhang JT
Neurosurg Rev; 2021 Apr; 44(2):1003-1015. PubMed ID: 32189095
[TBL] [Abstract][Full Text] [Related]
5. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
6. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
[TBL] [Abstract][Full Text] [Related]
8. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
Kiang KM; Chan AA; Leung GK
BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
[TBL] [Abstract][Full Text] [Related]
9. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.
Castelli J; Feuvret L; Haoming QC; Biau J; Jouglar E; Berger A; Truc G; Gutierrez FL; Morandi X; Le Reste PJ; Thillays F; Loussouarn D; Nouhaud E; Crehange G; Antoni D; Vauleon E; de Crevoisier R; Noel G
J Neurooncol; 2016 Aug; 129(1):85-92. PubMed ID: 27169763
[TBL] [Abstract][Full Text] [Related]
11. Treatments of gliosarcoma of the brain: a systematic review and meta-analysis.
Wang X; Jiang J; Liu M; You C
Acta Neurol Belg; 2021 Dec; 121(6):1789-1797. PubMed ID: 33156945
[TBL] [Abstract][Full Text] [Related]
12. Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcoma.
Dejonckheere CS; Böhner AMC; Koch D; Schmeel LC; Herrlinger U; Vatter H; Schneider M; Schuss P; Giordano FA; Köksal MA
Strahlenther Onkol; 2022 May; 198(5):468-474. PubMed ID: 34939129
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
Jin MC; Liu EK; Shi S; Gibbs IC; Thomas R; Recht L; Soltys SG; Pollom EL; Chang SD; Hayden Gephart M; Nagpal S; Li G
Front Oncol; 2020; 10():337. PubMed ID: 32219069
[No Abstract] [Full Text] [Related]
14. Clinical characteristics and disease-specific prognostic nomogram for primary gliosarcoma: a SEER population-based analysis.
Feng SS; Li HB; Fan F; Li J; Cao H; Xia ZW; Yang K; Zhu XS; Cheng TT; Cheng Q
Sci Rep; 2019 Jul; 9(1):10744. PubMed ID: 31341246
[TBL] [Abstract][Full Text] [Related]
15. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
[TBL] [Abstract][Full Text] [Related]
16. Gliosarcoma: a clinical and radiological analysis of 48 cases.
Yi X; Cao H; Tang H; Gong G; Hu Z; Liao W; Sun L; Chen BT; Li X
Eur Radiol; 2019 Jan; 29(1):429-438. PubMed ID: 29948068
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.
Frandsen S; Broholm H; Larsen VA; Grunnet K; Møller S; Poulsen HS; Michaelsen SR
Front Oncol; 2019; 9():1425. PubMed ID: 31921679
[No Abstract] [Full Text] [Related]
18. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
[TBL] [Abstract][Full Text] [Related]
19. [A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report].
Kalita O; Zlevorová M; Megová M; Vaverka M; Trojanec R; Tučková L
Klin Onkol; 2016; 29(6):454-459. PubMed ID: 27951723
[TBL] [Abstract][Full Text] [Related]
20. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
Butowski N; Chang SM; Lamborn KR; Polley MY; Pieper R; Costello JF; Vandenberg S; Parvataneni R; Nicole A; Sneed PK; Clarke J; Hsieh E; Costa BM; Reis RM; Hristova-Kazmierski M; Nicol SJ; Thornton DE; Prados MD
Neuro Oncol; 2011 Dec; 13(12):1331-8. PubMed ID: 21896554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
